Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
This intro highlights key habits to prevent budget mistakes and keep your spending aligned with your goals, offering actionable guidance for steady progress.
11,326 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
An Amazon Web Services leader pushes back on AI doom, saying AI will reshape jobs, not erase them. Meanwhile, Amazon ...
Japan grants regulatory approval for Ripple to launch RLUSD through SBI Group, signaling a turning point for major ri...
Billionaire investor Ken Griffin donates $26 million to fund the west wing of the Theodore Roosevelt Presidential Lib...
Two consumer stars with very different paths battle for investors' attention. One mixes health-forward fast-casual ex...
Apple is pursuing approval to source memory from a blacklisted Chinese supplier, a move that could shift supply dynam...
The data center build-out accelerating wave is reshaping where investors place bets. Beyond chips, three infrastructu...
Elon Musk publicly weighs in on Mackenzie Scott’s $26 billion giving, sparking a larger debate about the effectivenes...
Two AI-era stock stories headline this guide: Palantir as an undervalued growth play and Sandisk as a growth leader w...
As rates stay elevated amid market turbulence, three preferred stock ETFs are emerging as ballast for retirement port...
May 2026 hands investors a surprise: a big jump in M2 money supply could rekindle inflation pressures. Markets weigh ...
As cloud-native tools reshape how enterprises build and store data, investors must decide between GitLab and MongoDB....